Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepak Gurbani

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Bioorganic & Medicinal Chemistry|January 1, 2017
Studies of TAK1-centered polypharmacology with novel covalent TAK1 inhibitorsLi Tan, Deepak Gurbani, Ellen L Weisberg, et al.
Bioorganic & Medicinal Chemistry|December 25, 2016
Structure-guided development of covalent TAK1 inhibitorsLi Tan, Deepak Gurbani, Ellen L Weisberg, et al.
Journal of Medicinal Chemistry|July 31, 2014
Discovery of type II inhibitors of TGFβ-activated kinase 1 (TAK1) and mitogen-activated protein kinase kinase kinase kinase 2 (MAP4K2)Li Tan, Tyzoon Nomanbhoy, Deepak Gurbani, et al.
Cell Chemical Biology|April 16, 2019
Leveraging Compound Promiscuity to Identify Targetable Cysteines within the KinomeSuman Rao, Deepak Gurbani, Guangyan Du, et al.
Cell Chemical Biology|August 19, 2017
Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-α Inhibition for Cancer and Autoimmune DiseaseJuliane Totzke, Deepak Gurbani, Rene Raphemot, et al.
Journal of Medicinal Chemistry|February 24, 2023
Development of a Covalent Inhibitor of c-Jun N-Terminal Protein Kinase (JNK) 2/3 with Selectivity over JNK1Wenchao Lu, Yao Liu, Yang Gao, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Bioorganic & Medicinal Chemistry|January 1, 2017
Studies of TAK1-centered polypharmacology with novel covalent TAK1 inhibitorsLi Tan, Deepak Gurbani, Ellen L Weisberg, et al.
Bioorganic & Medicinal Chemistry|December 25, 2016
Structure-guided development of covalent TAK1 inhibitorsLi Tan, Deepak Gurbani, Ellen L Weisberg, et al.
Journal of Medicinal Chemistry|July 31, 2014
Discovery of type II inhibitors of TGFβ-activated kinase 1 (TAK1) and mitogen-activated protein kinase kinase kinase kinase 2 (MAP4K2)Li Tan, Tyzoon Nomanbhoy, Deepak Gurbani, et al.
Cell Chemical Biology|April 16, 2019
Leveraging Compound Promiscuity to Identify Targetable Cysteines within the KinomeSuman Rao, Deepak Gurbani, Guangyan Du, et al.
Cell Chemical Biology|August 19, 2017
Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-α Inhibition for Cancer and Autoimmune DiseaseJuliane Totzke, Deepak Gurbani, Rene Raphemot, et al.
Journal of Medicinal Chemistry|February 24, 2023
Development of a Covalent Inhibitor of c-Jun N-Terminal Protein Kinase (JNK) 2/3 with Selectivity over JNK1Wenchao Lu, Yao Liu, Yang Gao, et al.
Pageof 3